Optic pathway gliomas in adults

Neurosurgery

Volumn 74, Issue 3, 2014, Pages 273-279

  Shofty, Ben ^a,b   Constantini, Shlomi ^a,b   Bokstein, Felix ^c   Ram, Zvi ^a   Ben Sira, Liat ^d   Freedman, Sigal ^a   Vainer, Gilad ^e   Kesler, Anat ^f  

^a Dana Children's Hospital   (Israel)

^b Gilbert Israeli Neurofibromatosis Center   (Israel)

^c Neuro Oncology Service   (Israel)

^d Pediatric Neurology Unit   (Israel)

^e Department of Pathology ^*  (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Low grade glioma; Neurofibromatosis; NF1; OPG; Optic pathway gliomas

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; GLIOMA; HUMAN; NEUROFIBROMATOSIS; ONSET AGE; OPTIC PATHWAY GLIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; VISUAL IMPAIRMENT; VISUAL SYSTEM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OPTIC NERVE GLIOMA; OPTIC NERVE NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84896723436     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000257     Document Type: Article

References (29)

1. Shofty B, Constantini S, Freedman S, Ben-Sira L, Kesler A. Optic pathway gliomas: current position and future directions [in Hebrew]. Harefuah. 2010;149 (11):721-725, 748.
2. Binning MJ, Liu JK, Kestle JR, Brockmeyer DL, Walker ML. Optic pathway gliomas: a review. Neurosurg Focus. 2007;23(5):E2.
3. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology. 2004;63 (10):1944-1946.
4. Nicolin G, Parkin P, Mabbott D, et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer. 2009;53(7):1231-1237.
5. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer. 2006;42(12): 1807-1816.
6. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61 (3):189-198.
7. Fouladi M, Wallace D, Langston JW, et al. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer. 2003;97(4):1084-1092.
8. Dinh TT, Wang YY, Rosenfeld JV, Cherny M. Glioblastoma of the optic chiasm. J Clin Neurosci. 2007;14(5):502-505.
9. Miyamoto J, Sasajima H, Owada K, Mineura K. Surgical decision for adult optic glioma based on [18F]fluorodeoxyglucose positron emission tomography study. Neurol Med Chir (Tokyo). 2006;46(10):500-503.
10. Wabbels B, Demmler A, Seitz J, Woenckhaus M, Bloss HG, Lorenz B. Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol. 2004;242 (9):741-748.
11. Hoyt WF,Meshel LG, Lessell S, Schatz NJ, Suckling RD. Malignant optic glioma of adulthood. Brain. 1973;96(1):121-132.
12. Sorensen AG, Batchelor TT, Wen PY, Zhang WT, Jain RK. Response criteria for glioma. Nat Clin Pract Oncol. 2008;5(11):634-644.
13. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7): 1277-1280.
14. Weizman L, Ben Sira L, Joskowicz L, et al. Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI. Med Image Anal. 2012;16(1):177-188.
15. Shofty B, Weizman L, Joskowicz L, et al. MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm. Childs Nerv Syst. 2011;27(8):1265-1272.
16. Dodge HW Jr, Love JG, Craig WM, et al. Gliomas of the optic nerves. AMA Arch Neurol Psychiatry. 1958;79(6):607-621.
17. Winograd E, Pencovich N, Yalon M, Soffer D, Beni-Adani L, Constantini S. Malignant transformation in pediatric spinal intramedullary tumors: case-based update. Childs Nerv Syst. 2012;28(10):1679-1686.
18. Zoeller GK, Brathwaite CD, Sandberg DI.Malignant transformation of an optic pathway glioma without prior radiation therapy. J Neurosurg Pediatr. 2010;5(5): 507-510.
19. Ichimura K, Pearson DM, Kocialkowski S, et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncology. 2009;11(4):341-347.
20. Pollack IF, Hamilton RL, Sobol RW, et al. IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group. Childs Nerv Syst. 2011;27(1):87-94.
21. Frezza C, Tennant DA, Gottlieb E. IDH1 mutations in gliomas: when an enzyme loses its grip. Cancer Cell. 2010;17(1):7-9.
22. Shofty B, Ben-Sira L, Freedman S, et al. Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer. 2011;57(3):481-485.
23. Fisher MJ, Balcer L, Gutmann DH, et al. Neurofibromatosis type I associated optic glioma visual outcomes following chemotherapy: an international multicenter retrospective analysis. Neuro Oncol. 2010;12(6):ii19-ii20.
24. Dalla Via P, Opocher E, Pinello ML, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol. 2007;9(4):430-437.
25. Campagna M, Opocher E, Viscardi E, et al. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer. 2010;55(6):1083-1088.
26. Matloob S, Fan JC, Danesh-Meyer HV. Multifocal malignant optic glioma of adulthood presenting as acute anterior optic neuropathy. J Clin Neurosci. 2011;18(7):974-977.
27. Schroder S, Baumann-Schroder U, Hazim W, Haase W, Mautner VF. Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis [in German]. Klin Monatsbl Augenheilkd. 1999;215(6):349-354.
28. Chong AL, Pole JD, Scheinemann K, et al. Optic pathway gliomas in adolescence: time to challenge treatment choices? Neuro Oncology. 2013;15(3):391-400.
29. Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr. 2000;159(9):692-696.